Association of maternal serum α-fetoprotein with persistent placenta previa

E. L. Koster, J. S. Dashe, D. D. McIntire, R. M. Ramus

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Objective: To evaluate the relationship between maternal serum α-fetoprotein (MSAFP) and the risk of persistent placenta previa. Methods: We conducted a retrospective cohort study of singleton pregnancies with sonographic evidence of placenta previa at 15-20 weeks' gestation, between October 1991 and August 2000. Only pregnancies with MSAFP determination at 15-20 weeks' gestation and non-anomalous live-born infants ≥ 24 weeks' gestation were included. Pregnancies in which Cesarean delivery was performed for placenta previa were considered persistent; this was the primary outcome. Results: Of 275 women with previa at 15-20 weeks' gestation, 33 (12%) had previa at delivery. Trend analysis revealed a greater likelihood of persistent previa with increasing MSAFP values (p = 0.01). Mid-trimester MSAFP < 1 multiple of the median (MoM) was associated with a decreased incidence of persistence of 4%, significantly less than the risk at ≥ 1 MoM (16%; p = 0.01). Conclusions: There is an association between increasing MSAFP values and greater likelihood of persistent placenta previa. An MSAFP value < 1 MoM is associated with a reduction in the risk of persistence of previa to delivery.

Original languageEnglish (US)
Pages (from-to)3-7
Number of pages5
JournalJournal of Maternal-Fetal and Neonatal Medicine
Volume16
Issue number1
DOIs
StatePublished - Jul 2004

Fingerprint

Fetal Proteins
Placenta Previa
Mothers
Pregnancy
Serum
Risk Reduction Behavior
Cohort Studies
Retrospective Studies
Incidence

Keywords

  • Maternal serum α-fetoprotein
  • Persistent placenta previa

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this

Association of maternal serum α-fetoprotein with persistent placenta previa. / Koster, E. L.; Dashe, J. S.; McIntire, D. D.; Ramus, R. M.

In: Journal of Maternal-Fetal and Neonatal Medicine, Vol. 16, No. 1, 07.2004, p. 3-7.

Research output: Contribution to journalArticle

@article{2fd9c47acfc24b5db38abb05cd761834,
title = "Association of maternal serum α-fetoprotein with persistent placenta previa",
abstract = "Objective: To evaluate the relationship between maternal serum α-fetoprotein (MSAFP) and the risk of persistent placenta previa. Methods: We conducted a retrospective cohort study of singleton pregnancies with sonographic evidence of placenta previa at 15-20 weeks' gestation, between October 1991 and August 2000. Only pregnancies with MSAFP determination at 15-20 weeks' gestation and non-anomalous live-born infants ≥ 24 weeks' gestation were included. Pregnancies in which Cesarean delivery was performed for placenta previa were considered persistent; this was the primary outcome. Results: Of 275 women with previa at 15-20 weeks' gestation, 33 (12{\%}) had previa at delivery. Trend analysis revealed a greater likelihood of persistent previa with increasing MSAFP values (p = 0.01). Mid-trimester MSAFP < 1 multiple of the median (MoM) was associated with a decreased incidence of persistence of 4{\%}, significantly less than the risk at ≥ 1 MoM (16{\%}; p = 0.01). Conclusions: There is an association between increasing MSAFP values and greater likelihood of persistent placenta previa. An MSAFP value < 1 MoM is associated with a reduction in the risk of persistence of previa to delivery.",
keywords = "Maternal serum α-fetoprotein, Persistent placenta previa",
author = "Koster, {E. L.} and Dashe, {J. S.} and McIntire, {D. D.} and Ramus, {R. M.}",
year = "2004",
month = "7",
doi = "10.1080/14767050410001728935",
language = "English (US)",
volume = "16",
pages = "3--7",
journal = "Journal of Maternal-Fetal and Neonatal Medicine",
issn = "1476-7058",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Association of maternal serum α-fetoprotein with persistent placenta previa

AU - Koster, E. L.

AU - Dashe, J. S.

AU - McIntire, D. D.

AU - Ramus, R. M.

PY - 2004/7

Y1 - 2004/7

N2 - Objective: To evaluate the relationship between maternal serum α-fetoprotein (MSAFP) and the risk of persistent placenta previa. Methods: We conducted a retrospective cohort study of singleton pregnancies with sonographic evidence of placenta previa at 15-20 weeks' gestation, between October 1991 and August 2000. Only pregnancies with MSAFP determination at 15-20 weeks' gestation and non-anomalous live-born infants ≥ 24 weeks' gestation were included. Pregnancies in which Cesarean delivery was performed for placenta previa were considered persistent; this was the primary outcome. Results: Of 275 women with previa at 15-20 weeks' gestation, 33 (12%) had previa at delivery. Trend analysis revealed a greater likelihood of persistent previa with increasing MSAFP values (p = 0.01). Mid-trimester MSAFP < 1 multiple of the median (MoM) was associated with a decreased incidence of persistence of 4%, significantly less than the risk at ≥ 1 MoM (16%; p = 0.01). Conclusions: There is an association between increasing MSAFP values and greater likelihood of persistent placenta previa. An MSAFP value < 1 MoM is associated with a reduction in the risk of persistence of previa to delivery.

AB - Objective: To evaluate the relationship between maternal serum α-fetoprotein (MSAFP) and the risk of persistent placenta previa. Methods: We conducted a retrospective cohort study of singleton pregnancies with sonographic evidence of placenta previa at 15-20 weeks' gestation, between October 1991 and August 2000. Only pregnancies with MSAFP determination at 15-20 weeks' gestation and non-anomalous live-born infants ≥ 24 weeks' gestation were included. Pregnancies in which Cesarean delivery was performed for placenta previa were considered persistent; this was the primary outcome. Results: Of 275 women with previa at 15-20 weeks' gestation, 33 (12%) had previa at delivery. Trend analysis revealed a greater likelihood of persistent previa with increasing MSAFP values (p = 0.01). Mid-trimester MSAFP < 1 multiple of the median (MoM) was associated with a decreased incidence of persistence of 4%, significantly less than the risk at ≥ 1 MoM (16%; p = 0.01). Conclusions: There is an association between increasing MSAFP values and greater likelihood of persistent placenta previa. An MSAFP value < 1 MoM is associated with a reduction in the risk of persistence of previa to delivery.

KW - Maternal serum α-fetoprotein

KW - Persistent placenta previa

UR - http://www.scopus.com/inward/record.url?scp=4644337353&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4644337353&partnerID=8YFLogxK

U2 - 10.1080/14767050410001728935

DO - 10.1080/14767050410001728935

M3 - Article

C2 - 15370075

AN - SCOPUS:4644337353

VL - 16

SP - 3

EP - 7

JO - Journal of Maternal-Fetal and Neonatal Medicine

JF - Journal of Maternal-Fetal and Neonatal Medicine

SN - 1476-7058

IS - 1

ER -